SUJUNG PARK, M.D.
Hematology & Oncology Physician · NEWARK, DE
Individual Active NPI 1811218621
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 565 | 110,514 | $14,368,330 | $4,205,181 | $3,347,305 |
| 2023 | 421 | 83,683 | $9,567,817 | $2,985,474 | $2,373,432 |
| 2022 | 620 | 136,653 | $11,288,839 | $3,863,816 | $3,072,425 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 28,000 | $56 | $45 |
| J9267 | Injection, paclitaxel, 1 mg | 9,294 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 6,460 | $31 | $25 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 5,580 | $50 | $39 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 3,400 | $20 | $16 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 3,300 | $26 | $21 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,565 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 2,160 | $25 | $20 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 1,470 | $47 | $37 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 750 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 680 | $1 | $1 |
| J9045 | Injection, carboplatin, 50 mg | 448 | $3 | $3 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | C1-0011704 | DE |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Delaware
- NPI 1386720340
- NPI 1275976417
- NPI 1841269966
- NPI 1588614697
- NPI 1063743722
- NPI 1134486046
- NPI 1174665822
- NPI 1427008622
See all Hematology & Oncology Physician providers in Delaware →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.